TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,856,838 | -3.1% | 572,517 | -1.6% | 0.04% | +2.3% |
| Q2 2023 | $9,137,973 | -45.5% | 581,666 | -42.8% | 0.04% | -48.2% |
| Q1 2023 | $16,756,337 | -4.8% | 1,016,768 | -9.9% | 0.08% | -15.3% |
| Q4 2022 | $17,602,603 | +42.1% | 1,128,372 | +18.2% | 0.10% | +46.3% |
| Q3 2022 | $12,387,000 | -13.9% | 955,027 | -6.8% | 0.07% | -9.5% |
| Q2 2022 | $14,381,000 | +216.3% | 1,024,253 | +222.5% | 0.07% | +184.6% |
| Q1 2022 | $4,547,000 | +112.2% | 317,556 | +101.9% | 0.03% | +116.7% |
| Q4 2021 | $2,143,000 | +59.8% | 157,252 | +114.1% | 0.01% | +20.0% |
| Q1 2021 | $1,341,000 | +39.4% | 73,452 | +39.0% | 0.01% | +25.0% |
| Q4 2020 | $962,000 | -57.4% | 52,861 | -58.2% | 0.01% | -57.9% |
| Q3 2020 | $2,258,000 | +66.3% | 126,556 | +67.1% | 0.02% | +18.8% |
| Q2 2020 | $1,358,000 | +15.3% | 75,718 | -2.4% | 0.02% | -52.9% |
| Q1 2020 | $1,178,000 | -83.8% | 77,572 | -78.9% | 0.03% | -75.9% |
| Q4 2019 | $7,253,000 | +128.9% | 367,616 | +99.6% | 0.14% | +156.4% |
| Q3 2019 | $3,168,000 | +722.9% | 184,173 | +747.0% | 0.06% | +400.0% |
| Q2 2019 | $385,000 | – | 21,745 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |